Please ensure Javascript is enabled for purposes of website accessibility

Why STAAR Surgical Stock Is Dropping Today

By Prosper Junior Bakiny - Updated Feb 23, 2021 at 3:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There isn't much for long-term investors to worry about.

What happened

Shares of implantable lenses manufacturer STAAR Surgical Company (STAA 0.00%) are falling sharply on Tuesday and were down by 4.9% as of 2:08 p.m. EST, after dropping by as much as 12.3% earlier in the day. The company did not report any news, but the most likely reason it is losing altitude is that the broader market is having a difficult day of its own.

So what

The Nasdaq Composite opened sharply lower on Tuesday, a decline fueled by some of the largest technology companies in the U.S. The Dow Jones and the S&P 500 are also down as of this writing. This market rout seems to have dragged down other companies such as STAAR Surgical. Note that the healthcare company is gearing up to report its fourth-quarter and full-year 2020 financial results after the market close on Wednesday.

Piggy bank upside down on a table.

Image source: Getty Images.

At the very least, STAAR Surgical's top line will likely come in above the consensus analyst estimates. For its fourth quarter of 2020, which ended on Jan. 1, the company expects to report net sales of $46 million. On average, Wall Street analysts projected the company's net sales for the fourth quarter would be $43.85 million.

STAAR Surgical also thinks it will record net sales of $163 million for the full fiscal year 2020, which compares favorably to the average estimate of $161.73 million. Depending on other factors (such as the company's adjusted earnings and its guidance for the fiscal year 2021), STAAR Surgical's stock could fall even after it releases its quarterly update.

Now what

Investors shouldn't worry about daily fluctuations in stock prices. What's important to note about STAAR Surgical is that it performed decently well last year despite headwinds caused by the pandemic. Analysts expect the company's revenue to increase at an annual rate of 30% through the next five years. These factors (and others) make STAAR Surgical's stock worth considering, regardless of its struggles on the stock market today.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

STAAR Surgical Company Stock Quote
STAAR Surgical Company
$59.64 (0.00%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.